LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 117 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,704 | -42.3% | 1,444 | -31.0% | 0.00% | – |
Q2 2023 | $2,951 | +16.5% | 2,093 | +24.0% | 0.00% | – |
Q1 2023 | $2,532 | +176.7% | 1,688 | +115.9% | 0.00% | – |
Q4 2022 | $915 | -8.5% | 782 | -23.2% | 0.00% | – |
Q3 2022 | $1,000 | -88.9% | 1,018 | -81.2% | 0.00% | – |
Q2 2022 | $9,000 | +350.0% | 5,426 | +222.6% | 0.00% | – |
Q1 2022 | $2,000 | – | 1,682 | +84000.0% | 0.00% | – |
Q4 2021 | $0 | – | 2 | 0.0% | 0.00% | – |
Q3 2021 | $0 | – | 2 | -60.0% | 0.00% | – |
Q2 2021 | $0 | – | 5 | -99.0% | 0.00% | – |
Q4 2019 | $0 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $39,477,000 | 3.01% |
Raffles Associates | 2,080,536 | $2,351,000 | 2.51% |
Defender Capital, LLC. | 5,184,035 | $5,862,000 | 2.30% |
Prescott General Partners LLC | 1,851,851 | $2,093,000 | 0.16% |
DAFNA Capital Management LLC | 140,000 | $158,000 | 0.04% |
Fort Sheridan Advisors LLC | 83,931 | $95,000 | 0.03% |
Long Focus Capital Management, LLC | 215,000 | $243,000 | 0.02% |
XTX Topco Ltd | 72,807 | $82,000 | 0.02% |
Ergoteles LLC | 490,895 | $555,000 | 0.02% |
Beirne Wealth Consulting Services, LLC | 45,000 | $51,000 | 0.02% |